Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

New clot-busting stroke drug lowers risk of serious complications

Alteplase is currently seen as the standard of care for stroke treatment among many clinicians, but tenecteplase offers significant value. 

Thumbnail

Risk of COVID-related stroke highest soon after diagnosis

“These findings can inform diagnosis, treatment and care of stroke among patients with COVID-19,” one researcher said. 

What decades of data tell us about stroke rates in the U.S.

Researchers tracked 29 years of data, uncovering a mix of good news and concerning trends. 

Carotid endarterectomy may be a safer treatment option than carotid artery stenting

Researchers reviewed 26 years of data, sharing their findings in the European Journal of Vascular & Endovascular Surgery.

Thumbnail

Endovascular therapy less likely among Black stroke patients

Access to endovascular therapy does not appear to be the issue. 

Thumbnail

A fresh look at managing patients with type B aortic dissection

The new guideline calls for a “stepwise approach," followed by close clinical surveillance, when treating uncomplicated TBAD. In some cases, however, earlier endovascular treatments may be necessary. 

Thumbnail

Tracking non-primary PCI outcomes among men and women

The study's authors believe this to be the largest analysis of its kind. 

FDA announces recall of 95,000 directional atherectomy systems after 55 injuries

Significant issues have been reported with the catheter’s guidewire.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.